Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Laughton

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
IBRO Neuroscience Reports|June 28, 2021
Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of ageEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
AIDS (London, England)|June 2, 2021
Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of ageKirsten A Veldsman, Barbara Laughton, Anita Janse van Rensburg, et al.
Frontiers in Neuroanatomy|November 23, 2017
Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ARTSteven R Randall, Christopher M R Warton, Martha J Holmes, et al.
BMC Neuroscience|July 12, 2023
Correction to: Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controlsEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
BMC Neuroscience|February 24, 2023
Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controlsEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
Metabolic Brain Disease|December 7, 2017
Altered brain morphometry in 7-year old HIV-infected children on early ARTEmmanuel C Nwosu, Frances C Robertson, Martha J Holmes, et al.
BMJ Open|December 30, 2022
Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocolRupak Shivakoti, Amy L Slogrove, Barbara Laughton, et al.
Neuroimage. Clinical|January 5, 2021
MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infectionAmy S Graham, Martha J Holmes, Francesca Little, et al.
Journal of the International AIDS Society|July 14, 2021
Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: a longitudinal investigationKaylee S van Wyhe, Barbara Laughton, Mark F Cotton, et al.
Plos One|July 13, 2017
Longitudinal increases of brain metabolite levels in 5-10 year old childrenMartha J Holmes, Frances C Robertson, Francesca Little, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
IBRO Neuroscience Reports|June 28, 2021
Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of ageEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
AIDS (London, England)|June 2, 2021
Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of ageKirsten A Veldsman, Barbara Laughton, Anita Janse van Rensburg, et al.
Frontiers in Neuroanatomy|November 23, 2017
Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ARTSteven R Randall, Christopher M R Warton, Martha J Holmes, et al.
BMC Neuroscience|July 12, 2023
Correction to: Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controlsEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
BMC Neuroscience|February 24, 2023
Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controlsEmmanuel C Nwosu, Martha J Holmes, Mark F Cotton, et al.
Metabolic Brain Disease|December 7, 2017
Altered brain morphometry in 7-year old HIV-infected children on early ARTEmmanuel C Nwosu, Frances C Robertson, Martha J Holmes, et al.
BMJ Open|December 30, 2022
Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocolRupak Shivakoti, Amy L Slogrove, Barbara Laughton, et al.
Neuroimage. Clinical|January 5, 2021
MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infectionAmy S Graham, Martha J Holmes, Francesca Little, et al.
Journal of the International AIDS Society|July 14, 2021
Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: a longitudinal investigationKaylee S van Wyhe, Barbara Laughton, Mark F Cotton, et al.
Plos One|July 13, 2017
Longitudinal increases of brain metabolite levels in 5-10 year old childrenMartha J Holmes, Frances C Robertson, Francesca Little, et al.
Pageof 8